Dengue: A Re-Emerging Disease

Authors Information
Article Notes and Dates
To Cite : Sharifi Mood B, Mardani M. Dengue: A Re-Emerging Disease, Arch Clin Infect Dis. 2017 ;12(1):e27970. doi: 10.5812/archcid.27970.
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Acknowledgements
Footnote
References
  • 1. Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol. 2005; 2(1): 1[DOI][PubMed]
  • 2. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl)-16[DOI][PubMed]
  • 3. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. 2009; [PubMed]
  • 4. Simmons CP, Farrar JJ, Nguyen v V, Wills B. Dengue. N Engl J Med. 2012; 366(15): 1423-32[DOI][PubMed]
  • 5. World Health Organization . Dengue and severe dengue. Media centre; 2013;
  • 6. Cafferata ML, Bardach A, Rey-Ares L, Alcaraz A, Cormick G. , Gibbons L, et al. Dengue Epidemiology and Burden of Disease in Latin America and the Caribbean: A Systematic Review of the Literature and Meta-Analysis. Value in Health Regional Issues. 2013; 2: 347-56
  • 7. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002; 2(1): 33-42[PubMed]
  • 8. Mitchell-Foster K, Ayala EB, Breilh J, Spiegel J, Wilches AA, Leon TO, et al. Integrating participatory community mobilization processes to improve dengue prevention: an eco-bio-social scaling up of local success in Machala, Ecuador. Trans R Soc Trop Med Hyg. 2015; 109(2): 126-33[DOI][PubMed]
  • 9. de Sa Brito DT, de Siqueira VH, Marteleto MA. [Multiprofessional demand and clientele: influences and challenges for a Master's degree course in educational technology in the health sciences]. Cad Saude Publica. 1999; 15 Suppl 2: 45-54[PubMed]
  • 10. Helmstetter C, Flossdorf M, Peine M, Kupz A, Zhu J, Hegazy AN, et al. Individual T helper cells have a quantitative cytokine memory. Immunity. 2015; 42(1): 108-22[DOI][PubMed]
  • 11. Moraes GH, de Fatima Duarte E, Duarte EC. Determinants of mortality from severe dengue in Brazil: a population-based case-control study. Am J Trop Med Hyg. 2013; 88(4): 670-6[DOI][PubMed]
  • 12. Diaz-Quijano FA, Waldman EA. Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study. Am J Trop Med Hyg. 2012; 86(2): 328-34[DOI][PubMed]
  • 13. Hagenlocher M, Delmelle E, Casas I, Kienberger S. Assessing socioeconomic vulnerability to dengue fever in Cali, Colombia: statistical vs expert-based modeling. Int J Health Geogr. 2013; 12: 36[DOI][PubMed]
  • 14. Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV. Dengue and dengue haemorrhagic fever. Lancet. 1998; 352(9132): 971-7[PubMed]
  • 15. Hammon WM, Rudnick A, Sather GE. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science. 1960; 131(3407): 1102-3[PubMed]
  • 16. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969; 18(6): 954-71[PubMed]
  • 17. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Kalyanarooj S, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002; 8(12): 1474-9[DOI][PubMed]
  • 18. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012; 6(8)[DOI][PubMed]
  • 19. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013; 496(7446): 504-7[DOI][PubMed]
  • 20. Centers for Disease C Prevention. . Travel-associated Dengue surveillance - United States, 2006-2008. MMWR Morb Mortal Wkly Rep. 2010; 59(23): 715-9[PubMed]
  • 21. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjorup I, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis. 2007; 195(8): 1089-96[DOI][PubMed]
  • 22. Schmidt-Chanasit J, Tenner-Racz K, Poppert D, Emmerich P, Frank C, Dinges C, et al. Fatal dengue hemorrhagic fever imported into Germany. Infection. 2012; 40(4): 441-3[DOI][PubMed]
  • 23. Sabchareon A, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, Jiwariyavej V, et al. Dengue infection in children in Ratchaburi, Thailand: a cohort study. I. Epidemiology of symptomatic acute dengue infection in children, 2006-2009. PLoS Negl Trop Dis. 2012; 6(7)[DOI][PubMed]
  • 24. Gasparoni A, Avanzini A, Ravagni Probizer F, Chirico G, Rondini G, Severi F. IgG subclasses compared in maternal and cord serum and breast milk. Arch Dis Child. 1992; 67(1 Spec No): 41-3[PubMed]
  • 25. Pengsaa K, Yoksan S, Limkittikul K, Wisetsing P, Sirivichayakul C, Hutacharoen P, et al. Maternally transferred neutralising dengue antibodies in Thai infants: a pilot study. Ann Trop Paediatr. 2003; 23(3): 159-65[DOI][PubMed]
  • 26. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988; 239(4839): 476-81[PubMed]
  • 27. Low JG, Sung C, Wijaya L, Wei Y, Rathore APS, Watanabe S, et al. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet Infect Dis. 2014; 14: 706-15
  • 28. Tam DT, Ngoc TV, Tien NT, Kieu NT, Thuy TT, Thanh LT, et al. Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clin Infect Dis. 2012; 55(9): 1216-24[DOI][PubMed]
  • 29. WHO . Global strategy for dengue prevention control: 2012-2020. 2012;
  • 30. WHO . Report of a WHO technical working group meeting on dengue prevention and control. 2012;
  • 31. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. 2012; 380(9853): 1559-67[DOI][PubMed]
  • 32. Poole-Smith BK, Hemme RR, Delorey M, Felix G, Gonzalez AL, Amador M, et al. Comparison of vector competence of Aedes mediovittatus and Aedes aegypti for dengue virus: implications for dengue control in the Caribbean. PLoS Negl Trop Dis. 2015; 9(2)[DOI][PubMed]
  • 33. Manrique-Saide P, Che-Mendoza A, Barrera-Perez M, Guillermo-May G, Herrera-Bojorquez J, Dzul-Manzanilla F, et al. Use of insecticide-treated house screens to reduce infestations of dengue virus vectors, Mexico. Emerg Infect Dis. 2015; 21(2): 308-11[DOI][PubMed]
  • 34. Brusich M, Grieco J, Penney N, Tisgratog R, Ritthison W, Chareonviriyaphap T, et al. Targeting educational campaigns for prevention of malaria and dengue fever: an assessment in Thailand. Parasit Vectors. 2015; 8: 43[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Archives of Clinical Infectious Diseases accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check